The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

Plasmodium falciaprum

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

August 27, 2019 - 21:39 -- Open Access
Tags: 
Author(s): 
Esperança Sevene, Clifford G. Banda, Victor Mwapasa, et al.
Reference: 
Malaria Journal 2019 18:277, 20 August 2019

HIV-infected individuals on antiretroviral therapy (ART) require treatment with artemisinin-based combination therapy (ACT) when infected with malaria. Dihydroartemisinin–piperaquine (DPQ) is recommended for treatment of Plasmodium falciparum malaria, but its efficacy and safety has not been evaluated in HIV-infected individuals on ART, among whom drug–drug interactions are expected. Day-42 adequate clinical and parasitological response (ACPR) and incidence of adverse events were assessed in HIV-infected individuals on non-nucleoside reverse transcriptase inhibitor-based ART (efavirenz and nevirapine) with uncomplicated P. falciparum malaria treated with dihydroartemisinin–piperaquine.

Medical Condition: 

Computational prediction of protein interactions related to the invasion of erythrocytes by malarial parasites

December 2, 2014 - 16:06 -- Open Access
Author(s): 
Xuewu Liu, Yuxiao Huang, Jiao Liang, Shuai Zhang, Yinghui Li, Jun Wang, Yan Shen, Zhikai Xu and Ya Zhao
Reference: 
BMC Bioinformatics 2014, 15:393

In this study, an expectation maximization algorithm was used to estimate the probabilities of domain-domain interactions (DDIs). Estimates of DDI probabilities were then used to infer PPI probabilities.

Medical Condition: 

Synthesis and structure–activity relationships of antimalarial 4-oxo-3-carboxyl quinolones

April 7, 2010 - 11:14 -- Kabogo Ndegwa
Author(s): 
Yiqun Zhang, W. Armand Guiguemde, Martina Sigal, Fangyi Zhu, Michele C. Connelly, Solomon Nwaka, R. Kiplin Guy
Reference: 
Bioorganic & Medicinal Chemistry, Volume 18, Issue 7, 1 April 2010, Pages 2756-2766

The increasing prevalence of multi-drug-resistant Plasmodium falciparum drives the ongoing need for the development of new antimalarial drugs.

Organization: 
Medical Treatment: 

Transfusion Practice: Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol

March 31, 2010 - 12:19 -- Patrick Sampao
Author(s): 
Perry J.J. van Genderen, Dennis A. Hesselink, Jacob M. Bezemer, Pieter J. Wismans, David Overbosch
Reference: 
Transfusion, Volume 50, Issue 4, Date: April 2010, Pages: 787-794

Although exchange transfusion (ET) has been considered as a controversial adjunct therapy, we have not encountered any case fatality since ET was introduced as a standard adjunct therapy for patients with severe malaria.

Person: 
Medical Condition: 
Subscribe to RSS - Plasmodium falciaprum